Citation: | SUN Jinjie, HE Bosheng, WANG Yinmei, LI Weiwei. Translation of Disability Visual Analogue Scale score of inflammatory bowel diseases and test of its validation and reliability[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 98-102. DOI: 10.7619/jcmp.20232840 |
To translate the Inflammatory Bowel Disease Disability Visual Analogue Scale (IBD Disk) into Chinese and conduct cross-cultural adaptation, and to test its reliability and validity among patients with inflammatory bowel disease (IBD).
Based on the modified Brislin translation model, the IBD Disk was translated into Chinese through forward translation, back translation, group discussion, and cross-cultural adaptation. From January to December 2022, a convenience sampling method was used to select 299 IBD patients for investigation to verify the reliability and validity of the Scale.
The Chinese version of the IBD Disk includes 10 items, with decision values of 4.79 to 15.68 (>3.00), and P value was less than 0.05, indicating high discriminatory power for each item; the total Cronbach's α coefficient of the scale was 0.88, and the test-retest reliability was 0.87, indicating a good reproducibility of the scale; confirmatory factor analysis results indicated that the scale had ideal fit; Pearson correlation analysis results indicated that the total score of the IBD Disk was significantly positively correlated with the total score of the Inflammatory Bowel Disease Disability Index Scale (IBD-DI) (r=0.81, P < 0.001), suggesting good correlation between the IBD Disk and the IBD-DI.
The Chinese version of the IBD Disk has good reliability and validity, and is suitable to be used as a disability assessment tool for IBD patients in Chinese culture.
[1] |
孙晋洁. 炎症性肠病残疾评估管理研究进展[J]. 护士进修杂志, 2022, 37(22): 2050-2054.
|
[2] |
GHOSH S, LOUIS E, BEAUGERIE L, et al. Development of the IBD disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases[J]. Inflamm Bowel Dis, 2017, 23(3): 333-340. doi: 10.1097/MIB.0000000000001033
|
[3] |
王晓娇, 夏海鸥. 基于Brislin经典回译模型的新型翻译模型的构建及应用[J]. 护理学杂志, 2016, 31(7): 61-63. doi: 10.3870/j.issn.1001-4152.2016.07.061
|
[4] |
黄玺. 千叶跨专业协作能力量表的汉化及应用研究[D]. 沈阳: 中国医科大学, 2020.
|
[5] |
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年, 北京)[J]. 中华消化杂志, 2018, 38(5): 292-311. doi: 10.3760/cma.j.issn.0254-1432.2018.05.002
|
[6] |
孙晋洁, 孙永强. 炎症性肠病患者营养认知行为调查与营养不良分析[J]. 实用临床医药杂志, 2020, 24(2): 83-86. doi: 10.7619/jcmp.202002024
|
[7] |
许涵. 炎症性肠病患者残疾程度的临床研究[D]. 苏州: 苏州大学, 2019.
|
[8] |
STEVENS J. Applied multivariate statistics for the social sciences[J]. Journal of Educational Statistics, 2002, 47(2): 593-619.
|
[9] |
吴明隆. 问卷统计分析实务: SPSS操作与应用[M]. 重庆: 重庆大学出版社, 2010: 56-70.
|
[10] |
吴明隆. 结构方程模型: AMOS的操作与应用[M]. 2版. 重庆: 重庆大学出版社, 2010: 110-132.
|
[11] |
包云丽, 汪哲, 唐海茹, 等. 1990—2019年中国炎症性肠病疾病负担及变化趋势分析[J]. 中国全科医学, 2023, 26(36): 4581-4586. doi: 10.12114/j.issn.1007-9572.2023.0220
|
[12] |
张鲁敏, 顾芬, 任皎皎, 等. 护理领域患者报告结局的研究热点分析[J]. 医院管理论坛, 2021, 38(5): 50-55. doi: 10.3969/j.issn.1671-9069.2021.05.014
|
[13] |
倪飞霞, 蔡婷婷, 顾艳荭, 等. 患者报告结局测量信息系统在炎症性肠病患者中的研究进展[J]. 解放军护理杂志, 2021, 38(7): 64-66, 87. doi: 10.3969/j.issn.1008-9993.2021.07.016
|
[14] |
孙霁雯, 沈南平, 李祎涵, 等. 患者报告结局在医疗大数据中的临床应用价值[J]. 护士进修杂志, 2022, 37(3): 207-210.
|
[15] |
关宏峰, 杨丽娜, 杨悦. 美国患者报告结局测量工具在药物研发与注册中的应用[J]. 中国新药杂志, 2022, 31(2): 142-146.
|
[16] |
孙晋洁, 孙永强. 简体中文版炎症性肠病生存质量量表的信度及效度研究[J]. 护理研究, 2015, 29(21): 2581-2584. doi: 10.3969/j.issn.1009-6493.2015.21.008
|
[17] |
DIBLEY L, CZUBER-DOCHAN W, WOODWARD S, et al. P354 Refinement and confirmation of psychometric properties of the Inflammatory Bowel Disease Distress Scale(IBD-DS): a new tool to measure disease-specific distress[J]. J Crohns Colitis, 2018, 12(supplement_1): S282-S283.
|
[18] |
TADBIRI S, NACHURY M, BOUHNIK Y, et al. The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease[J]. J Crohns Colitis, 2021, 15(5): 766-773. doi: 10.1093/ecco-jcc/jjaa244
|
[19] |
BEATON D E, BOMBARDIER C, GUILLEMIN F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures[J]. Spine, 2000, 25(24): 3186-3191. doi: 10.1097/00007632-200012150-00014
|
[20] |
VAN ANDEL E M, KOOPMANN B D M, CROUWEL F, et al. Systematic review of development and content validity of patient-reported outcome measures in inflammatory bowel disease: do we measure what we measure[J]. J Crohns Colitis, 2020, 14(9): 1299-1315.
|
1. |
王晓娜,尹健,赵艳春. 右美托咪定联合利多卡因对脑肿瘤切除手术患者的脑保护效应. 贵州医科大学学报. 2023(02): 222-227 .
![]() | |
2. |
何丽丽,周兴,刘媛媛,雷亨发,何军民. 右美托咪定联合纳布啡或舒芬太尼用于老年患者钻孔引流术的临床效果. 江苏医药. 2023(05): 487-490 .
![]() | |
3. |
周美含. 右美托咪定对老年患者全身麻醉术后认知功能障碍的影响. 中华养生保健. 2023(02): 185-187 .
![]() | |
4. |
赵亮,徐阳阳. 右美托咪定对脑膜瘤患者脑源性神经生长因子水平及认知功能的影响. 中国肿瘤临床与康复. 2022(08): 902-905 .
![]() | |
5. |
郭其发,杨成亮,王艺丹,沈通桃. 无阿片药麻醉诱导对气管插管患者血流动力学的影响. 实用临床医药杂志. 2022(22): 56-59 .
![]() | |
6. |
申素峰,李景义,胡强夫. 右美托咪定与丙泊酚复合麻醉对脑膜瘤手术患者的麻醉效果及对血流动力学及脑组织的保护作用. 实用癌症杂志. 2022(12): 1971-1974 .
![]() |